Prescribing Opioids for Chronic Noncancer Pain in Primary Care: Risk Assessment

References

• . Chou R, Fanciullo GJ, Fine PG, . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. CDC Grand Rounds: Prescription Drug Overdoses—a U.S. Epidemic. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm. Accessed July 12, 2013
   Google Scholar
• . Mezei L, Murinson BB, Johns Hopkins Pain Curriculum Development Team. Pain education in North American medical schools. J Pain. 2011;12(12):1199–1208
   PubMed Web of Science ®Google Scholar
• . Watt-Watson J, McGillion M, Hunter J, . A survey of prelicensure pain curricula in health science faculties in Canadian universities. Pain Res Manag. 2009;14(6):439–444
   PubMed Web of Science ®Google Scholar
• . Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859–1865
   PubMed Web of Science ®Google Scholar
• . Spitz A, Moore AA, Papaleontiou M, Granieri E, Turner BJ, Reid MC. Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr. 2011;11:35
   PubMed Web of Science ®Google Scholar
• . Argoff CE, Kahan M, Sellers EM. Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence. J Opioid Manag. 2014;10(2):119–134
   PubMedGoogle Scholar
• . Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. National Opioid Use Guideline Group (NOUGG). http://nationalpaincentre.mcmaster.ca/opioid/. Accessed September 18, 2013
   Google Scholar
• . Gordon A. The five pillars of pain management. Pain Manag. 2012;2(4):335–344
   PubMedGoogle Scholar
• . Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442
   PubMed Web of Science ®Google Scholar
• . Butler SF, Budman SH, Fernandez KC, . Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1–2):144–156
   PubMed Web of Science ®Google Scholar
• . Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9(4):360–372
   PubMed Web of Science ®Google Scholar
• . Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36(4):383–395
   PubMed Web of Science ®Google Scholar
• . Chakravarthy B, Shah S, Lotfipour S. Prescription drug monitoring programs and other interventions to combat prescription opioid abuse. West J Emerg Med. 2012;13(5):422–425
   PubMedGoogle Scholar
• . Perrone J, DeRoos FJ, Nelson LS. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012. J Med Toxicol. 2012;8(4):341–352
   PubMedGoogle Scholar
• . Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15( 3 suppl):ES191–ES203
   PubMed Web of Science ®Google Scholar
• . Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302(2):123
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13(5):401–435
   PubMed Web of Science ®Google Scholar
• . Starrels JL, Fox AD, Kunins HV, Cunningham CO. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain. J Gen Intern Med. 2012;27(11):1521–1527
   PubMed Web of Science ®Google Scholar
• . Weissman DE, Haddox JD. Opioid pseudoaddiction—an iatrogenic syndrome. Pain. 1989;36(3):363–366
   PubMed Web of Science ®Google Scholar
• . Weissman DE. Pseudoaddiction #69. J Palliat Med. 2005;8(6):1283–1284
   PubMed Web of Science ®Google Scholar
• . Weissman DE. Understanding pseudoaddiction. J Pain Symptom Manage. 1994;9(2):74
   PubMed Web of Science ®Google Scholar
• . Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573–582
   PubMed Web of Science ®Google Scholar
• . Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med. 2008;9(8):1098–1106
   PubMed Web of Science ®Google Scholar
• . Brown J, Setnik B, Lee K, . Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. 2011;7(6):467–483
   PubMedGoogle Scholar
• . Onen NF, Barrette EP, Shacham E, Taniguchi T, Donovan M, Overton ET. A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic. Pain Pract. 2012;12(6):440–448
   PubMed Web of Science ®Google Scholar
• . Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–112
   PubMed Web of Science ®Google Scholar
• . U.S. Department of Justice, Drug Enforcement Administration. State Prescription Drug Monitoring Programs. Vol 2012. Washington, DC; 2011
   Google Scholar
• . Lamendola R. Pharmacists, doctors ignore prescription drug database. Health News Florida. http://wusfnews.wusf.usf.edu/post/pharmacists-doctors-ignore-prescription-drug-database. Accessed June 16, 2013
   Google Scholar
• . Stone MH. Management of borderline personality disorder: a review of psychotherapeutic approaches. World Psychiatry. 2006;5(1):15–20
   PubMed Web of Science ®Google Scholar
• . Kirsh KL, Jass C, Bennett DS, Hagen JE, Passik SD. Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care. 2007;5(3):219–226
   PubMedGoogle Scholar
• . Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage. 1995;10(8):599–603
   PubMed Web of Science ®Google Scholar
• . Cicero TJ, Lynskey M, Todorov A, Inciardi JA, Surratt HL. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain. 2008;139(1):127–135
   PubMed Web of Science ®Google Scholar
• . Seal KH, Shi Y, Cohen G, . Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947
   PubMed Web of Science ®Google Scholar
• . Tragesser SL, Jones RE, Robinson RJ, Stutler A, Stewart A. Borderline personality disorder features and risk for prescription opioid use disorders. J Pers Disord. 2013;27(4):427–441
   PubMed Web of Science ®Google Scholar
• . Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–146
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Abdi S, Atluri S, . American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician. 2012;15( 3 suppl):S67–S116
   PubMed Web of Science ®Google Scholar